Lysosome-Targeting Amplifiers of Reactive Oxygen Species as Anticancer Prodrugs
Language English Country Germany Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
- Keywords
- aminoferrocene, cancer, lysosomes, prodrugs, reactive oxygen species,
- MeSH
- Cell Line MeSH
- Neoplasms, Experimental drug therapy metabolism pathology MeSH
- Humans MeSH
- Lysosomes drug effects metabolism MeSH
- Mice MeSH
- Neoplasms drug therapy metabolism pathology MeSH
- Prodrugs chemistry pharmacology MeSH
- Cell Proliferation drug effects MeSH
- Antineoplastic Agents chemistry pharmacology MeSH
- Reactive Oxygen Species antagonists & inhibitors metabolism MeSH
- Drug Screening Assays, Antitumor MeSH
- Dose-Response Relationship, Drug MeSH
- Structure-Activity Relationship MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Prodrugs MeSH
- Antineoplastic Agents MeSH
- Reactive Oxygen Species MeSH
Cancer cells produce elevated levels of reactive oxygen species, which has been used to design cancer specific prodrugs. Their activation relies on at least a bimolecular process, in which a prodrug reacts with ROS. However, at low micromolar concentrations of the prodrugs and ROS, the activation is usually inefficient. Herein, we propose and validate a potentially general approach for solving this intrinsic problem of ROS-dependent prodrugs. In particular, known prodrug 4-(N-ferrocenyl-N-benzylaminocarbonyloxymethyl)phenylboronic acid pinacol ester was converted into its lysosome-specific analogue. Since lysosomes contain a higher concentration of active ROS than the cytoplasm, activation of the prodrug was facilitated with respect to the parent compound. Moreover, it was found to exhibit high anticancer activity in a variety of cancer cell lines (IC50 =3.5-7.2 μm) and in vivo (40 mg kg-1 , NK/Ly murine model) but remained weakly toxic towards non-malignant cells (IC50 =15-30 μm).
Danylo Halytsky Lviv National Medical University Pekarska str 69 79010 Lviv Ukraine
Institute of Experimental Botany AS CR Prague Czech Republik
References provided by Crossref.org
DNA Nanostructures for Rational Regulation of Cellular Organelles
An Endoplasmic Reticulum Specific Pro-amplifier of Reactive Oxygen Species in Cancer Cells